Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Edesa Biotech, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 18 | 23 | +5 |
| Shares | 261.1K | 385.6K | +124.4K (+47.7%) |
| Value | $1.37M | $2.85M | +$1.48M (+108.4%) |
New holders (7)
Institutions that held Edesa Biotech, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 15,564 | $115.0K | 0.00% |
| State Street Corp | 13,875 | $102.0K | 0.00% |
| Verition Fund Management LLC | 13,502 | $100.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,276 | $24.0K | 0.00% |
| FNY Investment Advisers, LLC | 1,640 | $12.0K | 0.01% |
| Barclays PLC | 300 | $2.00K | 0.00% |
| Morgan Stanley | 200 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Edesa Biotech, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Stifel Financial Corp | 23,438 | $124.0K |
| Bank of America Corp | 48 | $0 |